Search for: "BM"
Results 21 - 40
of 383
Sorted by Relevance
|
Sort by Date
9 Nov 2016, 11:10 am
In support of this Motion, BMS and Pfizer state as follows: 1. [read post]
16 Jul 2023, 10:17 am
” Oregon voters approved BM 114 last fall. [read post]
5 Jul 2012, 11:53 am
The Bureau of Mediation Services (BMS) recently issued a decision which could have broad implications. [read post]
13 Apr 2015, 3:00 am
Food and Drug Administration approved the use of BMS’s immunotherapy drug Opvido for the treatment of lung cancer. [read post]
8 Feb 2024, 12:59 pm
Baltimore Medical System (BMS), the largest Federally Qualified Health Center (FQHC) system in Maryland, Thursday was recently awarded two grants that will support new and ongoing efforts to address disparities in cancer early detection among patients in Baltimore. [read post]
17 Aug 2022, 12:19 pm
BMS will implement the expansion over the next three years, adding new staff, increased outreach and new referral programs with ... [read post]
19 Jun 2017, 11:43 am
(BMS) [corporate website]. [read post]
9 Dec 2024, 1:00 am
Sibanye BM Brazil (Pty.) [read post]
21 Apr 2021, 6:05 am
The BMS DEAL program will launch May 1 and is funded for ... [read post]
12 Sep 2012, 8:51 am
He indicated the City was notified by the BMS the part-time firefighters withdrew their petition to unionize. [read post]
11 Aug 2014, 1:24 pm
The court finds BM’s second objection frivolous. [read post]
17 Mar 2013, 1:30 am
BDR approached BMS for a license in early 2012. [read post]
30 Apr 2021, 10:23 am
Of that amount, BMS will pay approximately $41 million, plus interest, to the United States, and the remainder to states participating in the settlement. [read post]
20 Aug 2024, 1:25 pm
And because of this, BMS requires a claim-by-claim personal jurisdiction analysis in the FLSA context. [read post]
1 Feb 2011, 12:17 pm
So BM look at SAP. [read post]
9 Jan 2024, 4:18 am
(“Sawai”) to suspend the manufacture and sale of Sawai’s pharmaceutical product (“Sawai’s Product”) developed and sold as a generic drug of Bristol-Myers Squibb (“BMS”)’s cancer drug “Sprycel®” (Case No. 2023 (Yo) 30214; AIK represented BMS in this case). [read post]
12 Jun 2014, 3:03 pm
Therefore, we see no error in the selection of 2′-CDGas the lead compound here. [read post]
21 Nov 2008, 3:43 pm
" The manuscript is due to go to publishers in January, after Behrman's nondisclosure agreement with BMS expires.No word yet about the joy over at BMS related to this announcement.Source NY Daily News.Additional web pages: InSync Communication, Drug Expert Witness. [read post]
16 Nov 2011, 5:12 am
Nº 1029/AGIP/2011) Buenos Aires, 16 de noviembre de 2011 VISTO: La Ley Nº 2603 (BOCBA Nº 2.846), el Decreto 1126/1993 (BM Nº 19.603), el Decreto 674/1995 (BM Nº 20.084) y la Resolución Nº 430-SHyF/2001 (BOCBA Nº 1.170) y, CONSIDERANDO: Que por los Decretos Nros. 1126/93 y 674/95 se instrumentó oportunamente un régimen de percepción [read post]
8 Sep 2016, 3:07 pm
The majority also concluded that BMS’s unrelated California research provided an additional connection regarding plaintiffs’ claims that BMS negligently researched the subject product, as well as increasing BMS’s overall contact with California. [read post]
